Cannabis may help some people with ADHD manage symptoms such as restlessness and impulsivity – but research suggests it could make other symptoms worse.
Continue reading...
Curaleaf Laboratories renews its headline sponsorship of the Cannabis Health Symposium: London, having also backed the event’s inaugural edition in 2025. Cannabis Health, the clinical education platform powered by Prohibition […]
Continue reading...
Early-bird tickets for the Cannabis Health Symposium’s return to London close on Friday, September 4, with the £175 rate rising to standard pricing once the window shuts. It comes at […]
Continue reading...
Employers do not need a bespoke cannabis policy, their existing medicines, disability and occupational health processes should be applied.
Continue reading...
In the eight years since, the NHS has issued just five prescriptions for unlicenced specials cannabis medicines, creating a two-tier system with access only to those who can afford to pay for it.
Continue reading...
Sean McKinle of Origin CBD explores the emerging dangers of synthetic and semi-synthetic cannabinoids in Europe, both for businesses and consumers.
Continue reading...
Welcome to the first edition of ‘Medical Cannabis in the Workplace’, a new series produced by Cannabis Health and Releaf which aims to provide employers, HR teams and line managers with […]
Continue reading...
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
Continue reading...
Medical cannabis has been legal in the UK since 2018, but for many patients, taking or carrying their prescribed medication in public still comes with uncertainty. Since launching its legal […]
Continue reading...
In this bi-weekly series, Dr Sue Clenton explores the growing interest and potential of cannabinoid-based therapies to address unmet needs in women’s health conditions.
Continue reading...
Devon Partnership NHS Trust has approved procedures for patients to continue taking their prescribed cannabis-based medications while in hospital.
Continue reading...